Cargando…
Des-γ-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma
AIM: Des-γ-carboxyprothrombin (DCP) has been used as a tumor marker for hepatocellular carcinoma (HCC). Recently the DCP/NX-DCP ratio, calculated by dividing DCP by NX-DCP, has been reported useful in detecting HCC. The purpose of this study is to clarify the significance of DCP and NX-DCP expressio...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349810/ https://www.ncbi.nlm.nih.gov/pubmed/25739032 http://dx.doi.org/10.1371/journal.pone.0118452 |
_version_ | 1782360090973569024 |
---|---|
author | Sumi, Akiko Akiba, Jun Ogasawara, Sachiko Nakayama, Masamichi Nomura, Yoriko Yasumoto, Makiko Sanada, Sakiko Nakashima, Osamu Abe, Toshi Yano, Hirohisa |
author_facet | Sumi, Akiko Akiba, Jun Ogasawara, Sachiko Nakayama, Masamichi Nomura, Yoriko Yasumoto, Makiko Sanada, Sakiko Nakashima, Osamu Abe, Toshi Yano, Hirohisa |
author_sort | Sumi, Akiko |
collection | PubMed |
description | AIM: Des-γ-carboxyprothrombin (DCP) has been used as a tumor marker for hepatocellular carcinoma (HCC). Recently the DCP/NX-DCP ratio, calculated by dividing DCP by NX-DCP, has been reported useful in detecting HCC. The purpose of this study is to clarify the significance of DCP and NX-DCP expression in HCC tissues. METHODS: HCC and non-HCC tissue samples were obtained from 157 patients and were immunohistochemically examined for DCP and NX-DCP expression using anti-DCP antibody and anti-NX-DCP antibody. DCP and NX-DCP expression scores were calculated by multiplying staining intensity grade by percentage of stained area. Serum DCP and NX-DCP levels were determined in 89 patients. We evaluated the relationship between tumor expression, serum level, and pathomorphological findings. RESULTS: Intrahepatic metastasis (im) was significantly more frequent in cases with high DCP expression than in cases with low DCP expression. High NX-DCP expression was associated with significantly lower histological grade, and less frequent im or portal vein invasion (vp) than low NX-DCP expression. Serum DCP was correlated with DCP expression, but serum NX-DCP was not correlated with NX-DCP expression. DCP-positive (≥40 mAU/L), NX-DCP-positive (≥90 mAU/L), and DCP/NX-DCP ratio-positive (≥1.5) cases were associated with significantly larger tumor size and more frequent vp than negative cases. DCP was rarely expressed, but NX-DCP was frequently expressed in non-cancerous liver tissues. Patients with NX-DCP expression-negative tumors showed a lower survival rate than those with NX-DCP expression-positive tumors (p = 0.04), whereas the survival in serum NX-DCP-positive cases was lower than that of serum negative cases (p = 0.02). CONCLUSIONS: DCP and NX-DCP were produced in HCC tissues, but differed in expression level and biological properties. DCP expression, serum DCP or NX-DCP level, and DCP/NX-DCP ratio were closely related to malignant properties of HCC. |
format | Online Article Text |
id | pubmed-4349810 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-43498102015-03-17 Des-γ-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma Sumi, Akiko Akiba, Jun Ogasawara, Sachiko Nakayama, Masamichi Nomura, Yoriko Yasumoto, Makiko Sanada, Sakiko Nakashima, Osamu Abe, Toshi Yano, Hirohisa PLoS One Research Article AIM: Des-γ-carboxyprothrombin (DCP) has been used as a tumor marker for hepatocellular carcinoma (HCC). Recently the DCP/NX-DCP ratio, calculated by dividing DCP by NX-DCP, has been reported useful in detecting HCC. The purpose of this study is to clarify the significance of DCP and NX-DCP expression in HCC tissues. METHODS: HCC and non-HCC tissue samples were obtained from 157 patients and were immunohistochemically examined for DCP and NX-DCP expression using anti-DCP antibody and anti-NX-DCP antibody. DCP and NX-DCP expression scores were calculated by multiplying staining intensity grade by percentage of stained area. Serum DCP and NX-DCP levels were determined in 89 patients. We evaluated the relationship between tumor expression, serum level, and pathomorphological findings. RESULTS: Intrahepatic metastasis (im) was significantly more frequent in cases with high DCP expression than in cases with low DCP expression. High NX-DCP expression was associated with significantly lower histological grade, and less frequent im or portal vein invasion (vp) than low NX-DCP expression. Serum DCP was correlated with DCP expression, but serum NX-DCP was not correlated with NX-DCP expression. DCP-positive (≥40 mAU/L), NX-DCP-positive (≥90 mAU/L), and DCP/NX-DCP ratio-positive (≥1.5) cases were associated with significantly larger tumor size and more frequent vp than negative cases. DCP was rarely expressed, but NX-DCP was frequently expressed in non-cancerous liver tissues. Patients with NX-DCP expression-negative tumors showed a lower survival rate than those with NX-DCP expression-positive tumors (p = 0.04), whereas the survival in serum NX-DCP-positive cases was lower than that of serum negative cases (p = 0.02). CONCLUSIONS: DCP and NX-DCP were produced in HCC tissues, but differed in expression level and biological properties. DCP expression, serum DCP or NX-DCP level, and DCP/NX-DCP ratio were closely related to malignant properties of HCC. Public Library of Science 2015-03-04 /pmc/articles/PMC4349810/ /pubmed/25739032 http://dx.doi.org/10.1371/journal.pone.0118452 Text en © 2015 Sumi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Sumi, Akiko Akiba, Jun Ogasawara, Sachiko Nakayama, Masamichi Nomura, Yoriko Yasumoto, Makiko Sanada, Sakiko Nakashima, Osamu Abe, Toshi Yano, Hirohisa Des-γ-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma |
title | Des-γ-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma |
title_full | Des-γ-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma |
title_fullStr | Des-γ-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma |
title_full_unstemmed | Des-γ-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma |
title_short | Des-γ-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma |
title_sort | des-γ-carboxyprothrombin (dcp) and nx-dcp expressions and their relationship with clinicopathological features in hepatocellular carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349810/ https://www.ncbi.nlm.nih.gov/pubmed/25739032 http://dx.doi.org/10.1371/journal.pone.0118452 |
work_keys_str_mv | AT sumiakiko desgcarboxyprothrombindcpandnxdcpexpressionsandtheirrelationshipwithclinicopathologicalfeaturesinhepatocellularcarcinoma AT akibajun desgcarboxyprothrombindcpandnxdcpexpressionsandtheirrelationshipwithclinicopathologicalfeaturesinhepatocellularcarcinoma AT ogasawarasachiko desgcarboxyprothrombindcpandnxdcpexpressionsandtheirrelationshipwithclinicopathologicalfeaturesinhepatocellularcarcinoma AT nakayamamasamichi desgcarboxyprothrombindcpandnxdcpexpressionsandtheirrelationshipwithclinicopathologicalfeaturesinhepatocellularcarcinoma AT nomurayoriko desgcarboxyprothrombindcpandnxdcpexpressionsandtheirrelationshipwithclinicopathologicalfeaturesinhepatocellularcarcinoma AT yasumotomakiko desgcarboxyprothrombindcpandnxdcpexpressionsandtheirrelationshipwithclinicopathologicalfeaturesinhepatocellularcarcinoma AT sanadasakiko desgcarboxyprothrombindcpandnxdcpexpressionsandtheirrelationshipwithclinicopathologicalfeaturesinhepatocellularcarcinoma AT nakashimaosamu desgcarboxyprothrombindcpandnxdcpexpressionsandtheirrelationshipwithclinicopathologicalfeaturesinhepatocellularcarcinoma AT abetoshi desgcarboxyprothrombindcpandnxdcpexpressionsandtheirrelationshipwithclinicopathologicalfeaturesinhepatocellularcarcinoma AT yanohirohisa desgcarboxyprothrombindcpandnxdcpexpressionsandtheirrelationshipwithclinicopathologicalfeaturesinhepatocellularcarcinoma |